Status:
NOT_YET_RECRUITING
Multicomponent FIBROWALK Therapy Plus Unified Protocol for Emotional Regulation in Individuals With Fibromyalgia
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Fibromyalgia (FM)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, sleep disturbances, and cognitive dysfunction. Although the FIBROWALK multicomponent program improves physical functional...
Eligibility Criteria
Inclusion
- Adults diagnosed with fibromyalgia, according to the 2011 American College of Rheumatology (ACR) modified criteria.
- Aged 18 or older.
Exclusion
- Individuals with psychotic disorders, substance abuse, or severe cognitive impairment (based on medical evaluation).
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT06906991
Start Date
May 15 2025
End Date
June 1 2026
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall Hebron University Hospital
Barcelona, Spain, 08035